Assessment of treatment for patients with primary ductal carcinoma in situ in the breast

[1] Smigel K(1995)Breast cancer death rates decline for white women J Natl Cancer Inst 87 173-173

[2] Garfinkel L(1994)Changing trends. An overview of breast cancer incidence and mortality Cancer 74 222-7

[3] Boring C(1997)Incidence and treatment of ductal carcinoma in situ of the breast Eur J Cancer 33 10-11

[4] Heath C(1996)Histological grading of ductal carcinoma in situ (DCIS) (abstract) Breast Cancer Res Treat 41 221-221

[5] Silverstein MJ(1993)One century of mammary carcinoma in situ: what have we learned? Am J Clin Pathol 100 654-61

[6] Berardo MD(1998)Assessing genetic markers of tumour progression in the context of intra-tumour heterogeneity Cytometry 31 67-73

[7] Hilsenbeck SG(1994)Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification: a study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity Semin Diagn Pathol 11 208-14

[8] Prosser J(1993)Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer N Engl J Med 328 1581-6

[9] Allred DC(1996)An improved statistical approach: can it clarify the role of new prognostic factors for breast cancer? Eur J Cancer 32A 1949-56

[10] Fechner RE(1989)Mammographically detected duct carcinoma in situ: frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence Cancer 63 618-24

[1] Smigel K(1995)Breast cancer death rates decline for white women J Natl Cancer Inst 87 173-173

[2] Garfinkel L(1994)Changing trends. An overview of breast cancer incidence and mortality Cancer 74 222-7

[3] Boring C(1997)Incidence and treatment of ductal carcinoma in situ of the breast Eur J Cancer 33 10-11

[4] Heath C(1996)Histological grading of ductal carcinoma in situ (DCIS) (abstract) Breast Cancer Res Treat 41 221-221

[5] Silverstein MJ(1993)One century of mammary carcinoma in situ: what have we learned? Am J Clin Pathol 100 654-61

[6] Berardo MD(1998)Assessing genetic markers of tumour progression in the context of intra-tumour heterogeneity Cytometry 31 67-73

[7] Hilsenbeck SG(1994)Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification: a study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity Semin Diagn Pathol 11 208-14

[8] Prosser J(1993)Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer N Engl J Med 328 1581-6

[9] Allred DC(1996)An improved statistical approach: can it clarify the role of new prognostic factors for breast cancer? Eur J Cancer 32A 1949-56

[10] Fechner RE(1989)Mammographically detected duct carcinoma in situ: frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence Cancer 63 618-24